Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosisShuoyi Jiang, Xinliang Mao, Jinbao Liu et al.|Cell Death and Disease|2021Cited by 36
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label studyLijuan Deng, Jun Zhu, Zhiming Li et al.|American Journal of Hematology|2023Cited by 18
AML1-ETO-positive acute myeloid leukemia presents different phenotype in pediatric and adult patientsGuopan Yu, Dan Xu, Zhao Yin et al.|Unknown|2020Cited by 0